
|Videos|December 23, 2020
Dr. Adam J. Gadzinski describes the emergence of precision medicine in prostate cancer
Author(s)Urology Times staff
Urologist Adam J. Gadzinski, MD, MS, shares his excitement about the dawn of the precision medicine era in prostate cancer.
Advertisement
In this video, Adam J. Gadzinski, MD, MS, highlights how precision medicine in prostate cancer was a key topic at the 2020 Society of Urologic Oncology Annual Meeting and marks the next great leap forward in the field. Gadzinski is an acting instructor of urologic oncology at the Urology Clinic at the University of Washington Medical Center.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617
3
FDA approves cefepime and zidebactam for complicated UTI
4
FDA updates in urology: May 2026
5











